These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 17928410)

  • 21. Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule.
    Fliser D
    Eur J Clin Invest; 2005 Feb; 35(2):71-9. PubMed ID: 15667575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature.
    Visser M; Paulus WJ; Vermeulen MA; Richir MC; Davids M; Wisselink W; de Mol BA; van Leeuwen PA
    Eur J Heart Fail; 2010 Dec; 12(12):1274-81. PubMed ID: 20923854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury.
    Stühlinger MC; Conci E; Haubner BJ; Stocker EM; Schwaighofer J; Cooke JP; Tsao PS; Pachinger O; Metzler B
    Cardiovasc Res; 2007 Jul; 75(2):417-25. PubMed ID: 17559823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease.
    Ueda S; Yamagishi S; Kaida Y; Okuda S
    Nephrology (Carlton); 2007 Dec; 12(6):582-90. PubMed ID: 17995585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease?
    Fliser D; Kielstein JT; Haller H; Bode-Böger SM
    Kidney Int Suppl; 2003 May; (84):S37-40. PubMed ID: 12694305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in endothelial cells by nitric oxide deficiency.
    Smirnova IV; Sawamura T; Goligorsky MS
    Am J Physiol Renal Physiol; 2004 Jul; 287(1):F25-32. PubMed ID: 15010359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M; Liu L; Guo Z; Xiong Y
    Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism.
    Wilcken DE; Sim AS; Wang J; Wang XL
    Mol Genet Metab; 2007 Aug; 91(4):309-17; discussion 308. PubMed ID: 17560156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons.
    Selley ML
    J Neurosci Res; 2004 Jul; 77(1):90-3. PubMed ID: 15197741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New pathways to renal damage: role of ADMA in retarding renal disease progression.
    Ueda S; Yamagishi S; Okuda S
    J Nephrol; 2010; 23(4):377-86. PubMed ID: 20349427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced asymmetric dimethylarginine accumulation through inhibition of the type I protein arginine methyltransferases promotes renal fibrosis in obstructed kidneys.
    Wu M; Lin P; Li L; Chen D; Yang X; Xu L; Zhou B; Wang C; Zhang Y; Luo C; Ye C
    FASEB J; 2019 Jun; 33(6):6948-6956. PubMed ID: 30840839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methylarginies-induced endothelial dysfunction in chronic kidney disease].
    Kimura K
    Yakugaku Zasshi; 2012; 132(4):443-8. PubMed ID: 22465920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired L-arginine uptake but not arginase contributes to endothelial dysfunction in rats with chronic kidney disease.
    Martens CR; Kuczmarski JM; Lennon-Edwards S; Edwards DG
    J Cardiovasc Pharmacol; 2014 Jan; 63(1):40-8. PubMed ID: 24084210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The enzymatic machinery for ADMA synthesis and degradation is fully expressed in human adipocytes.
    Spoto B; Parlongo RM; Parlongo G; Sgro' E; Zoccali C
    J Nephrol; 2007; 20(5):554-9. PubMed ID: 17918140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. There is no direct competition between arginase and nitric oxide synthase for the common substrate l-arginine.
    Momma TY; Ottaviani JI
    Nitric Oxide; 2022 Dec; 129():16-24. PubMed ID: 36126859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
    Böger RH; Ron ES
    Altern Med Rev; 2005 Mar; 10(1):14-23. PubMed ID: 15771559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells.
    Monsalve E; Oviedo PJ; García-Pérez MA; Tarín JJ; Cano A; Hermenegildo C
    Cardiovasc Res; 2007 Jan; 73(1):66-72. PubMed ID: 17097077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?
    Chan NN; Chan JC
    Diabetologia; 2002 Dec; 45(12):1609-16. PubMed ID: 12488950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADMA and NOS regulation in chronic renal disease: beyond the old rivalry for l-arginine.
    Dobrian AD
    Kidney Int; 2012 Apr; 81(8):722-4. PubMed ID: 22460653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting on Asymmetric Dimethylarginine-Related Nitric Oxide-Reactive Oxygen Species Imbalance to Reprogram the Development of Hypertension.
    Tain YL; Hsu CN
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27918455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.